Digital Health Startups Focused on COPD Management File IPO Prospectus

Health management for chronic diseases has always been a key focus of internet healthcare. VCBeat has previously introduced to readers aboutDiabetes、TumorThis article introduces several internet healthcare companies focusing on COPD and the apps they have developed.

Global Status of COPD

COPD stands for Chronic Obstructive Pulmonary Disease. It is a common chronic respiratory disease characterized by airflow limitation, encompassing chronic bronchitis and emphysema, which can further progress to cor pulmonale and respiratory failure. With its high prevalence, elevated mortality rate, and substantial socioeconomic burden, COPD has become a significant public health issue affecting human health. Data indicate that the prevalence of COPD among individuals aged 40 and older worldwide has reached 9%–10%. This chronic respiratory disease is not only highly prevalent but also associated with a high mortality rate; statistics show that one person dies from this disease every 11 seconds globally.

Although there is already extensive research on COPD, there is still no definitive explanation for its specific etiology. It is generally believed that the primary causes are smoking and significant exposure to harmful gases. Furthermore, as COPD is a chronic respiratory disease, strengthening management control and providing more comprehensive health guidance are crucial during the treatment and rehabilitation process.

Overview of COPD-Related Apps

A VCBeat survey revealed that there are currently few professional apps dedicated to chronic obstructive pulmonary disease (COPD). Searches using “COPD” as a keyword on major Chinese Android platforms yielded only about 20 related applications, while approximately 10 products were found in Apple’s App Store. These applications primarily fall into two categories: those designed for healthcare professionals and those for patients. Apps targeted at physicians mainly offer features such as diagnostic and treatment plan formulation and disease progress documentation, whereas patient-oriented apps typically include functionalities for symptom tracking, health guidance, and patient social networking.

Introduction to Several Major COPD-Related Apps

App: COPD Dongdong Developer: Beijing Mandian Life Technology Co., Ltd.

COPD Dongdong is China’s first disease management software for chronic obstructive pulmonary disease (COPD). Featuring a built-in pedometer, it enables patients to perform simple self-administered six-minute walk tests and presents the results through intuitive charts. Additionally, the app provides regularly updated COPD health tips, offering effective health guidance to patients while helping family members gain greater knowledge to better support rehabilitation and care for COPD patients.

Beijing Mandian Life Technology Co., Ltd., the developer of this software, was founded in 2012 and specializes in mobile health and healthcare. Its flagship product is a fitness and weight-loss pedometer app named “Dongdong.” The company has also launched other apps, including Dongdong Pedometer and Dongdong for Diabetes. Notably, the “Dongdong” fitness and weight-loss pedometer has achieved considerable success in European and American markets. In September 2014, the company secured RMB 10 million in Series A funding from Ceyuan Ventures.

App: COPD Assessment Developer: Shanghai Ruiyi Information Technology Co., Ltd.

COPD is a mobile application designed for healthcare professionals, featuring functionalities such as disease record-keeping and treatment strategy assessment. The app was developed by Shanghai Ruiyi Information Technology Co., Ltd., a technology startup founded in 2011 that is dedicated to providing physicians with professional and personalized medical information services. The company’s main products include:* **Literature Services:** By integrating major domestic and international medical literature databases, the company offers free online reading and downloading services to physicians, as well as proxy search and retrieval services for select users.* **Online Video Interactive Academic Conference Services (One-on-One or Multi-party):** These services facilitate real-time, remote multimedia interactions for one-to-many and many-to-many conferences, including pharmaceutical academic conferences, product briefings, and academic seminars/discussions.* **Professional Medical News:** This includes updates on pharmaceutical industry trends and health policies, advances in domestic and international medical research and clinical practices, drug information, diagnostic and treatment guidelines, and clinical case studies.Currently, the company is also developing internet healthcare-related applications, electronic medical information systems, and online medical assistance centers. In 2012, the company secured millions of US dollars in Series A funding from Matrix Partners China.

App: COPD Control Developer: Almirall

"COPD Control" is an app developed by the renowned pharmaceutical company Almirall, designed to track the treatment and disease progression of patients with chronic obstructive pulmonary disease (COPD) and report relevant data to physicians in real time.

Almirall is a long-established Spanish pharmaceutical company founded in 1943 and headquartered in Barcelona. In 2013, the company reported total revenues exceeding €825 million and employed more than 3,000 people, becoming Spain’s leading independently research-driven pharmaceutical company.

App: The COPD Pocket Consultant Guide Developer: COPD Foundation, Inc.

The COPD Pocket Consultant Guide (PCG) is also a professional app designed for healthcare providers. It enables physicians to document patients’ symptoms and signs, respiratory status, and disease exacerbations, thereby facilitating clinical analysis and providing treatment options along with relevant medication information.

The developer of this app is the COPD Foundation, Inc. This foundation is dedicated to improving the quality of life for patients with chronic obstructive pulmonary disease (COPD) by developing relevant programs that promote research, education, early diagnosis, and enhanced treatment. Established in 2004 and headquartered in Washington, D.C., United States, the foundation is a non-profit organization.

If you are aware of more startup projects in the field of COPD, please feel free to contact us or submit your contributions to our email address: vb@vcbeat.top.

(For the latest updates on digital health entrepreneurship, please follow VCBeat’s WeChat official account: vcbeat. We also welcome you to engage with us on topics of interest, contact us via WeChat, and share your research insights.)